- Home
- DDS vs ELAN Comparison
DDS vs ELAN Comparison
Compare DDS & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDS
- ELAN
- Stock Information
- Founded
- DDS 1938
- ELAN 1954
- Country
- DDS United States
- ELAN United States
- Employees
- DDS N/A
- ELAN N/A
- Industry
- DDS Department/Specialty Retail Stores
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- DDS Consumer Discretionary
- ELAN Health Care
- Exchange
- DDS Nasdaq
- ELAN Nasdaq
- Market Cap
- DDS 7.0B
- ELAN 6.3B
- IPO Year
- DDS N/A
- ELAN 2018
- Fundamental
- Price
- DDS $466.76
- ELAN $12.01
- Analyst Decision
- DDS Sell
- ELAN Buy
- Analyst Count
- DDS 2
- ELAN 7
- Target Price
- DDS $324.00
- ELAN $16.43
- AVG Volume (30 Days)
- DDS 127.7K
- ELAN 4.1M
- Earning Date
- DDS 02-24-2025
- ELAN 02-24-2025
- Dividend Yield
- DDS 0.21%
- ELAN N/A
- EPS Growth
- DDS N/A
- ELAN N/A
- EPS
- DDS 38.87
- ELAN 0.41
- Revenue
- DDS $6,697,476,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- DDS N/A
- ELAN $2.22
- Revenue Next Year
- DDS $0.41
- ELAN $2.72
- P/E Ratio
- DDS $12.01
- ELAN $29.13
- Revenue Growth
- DDS N/A
- ELAN 1.99
- 52 Week Low
- DDS $328.00
- ELAN $11.11
- 52 Week High
- DDS $476.48
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- DDS 60.51
- ELAN 48.39
- Support Level
- DDS $432.39
- ELAN $11.11
- Resistance Level
- DDS $460.00
- ELAN $12.37
- Average True Range (ATR)
- DDS 15.06
- ELAN 0.38
- MACD
- DDS 0.41
- ELAN 0.06
- Stochastic Oscillator
- DDS 100.00
- ELAN 68.85
About DDS Dillard's Inc.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.